Invention Grant
- Patent Title: Immunogenic composition for use in vaccination against staphylococci
-
Application No.: US16046505Application Date: 2018-07-26
-
Publication No.: US10548963B2Publication Date: 2020-02-04
- Inventor: Cindy Castado , Nicolas Pierre Fernand Lecrenier , Cecile Anne Neyt , Jan Poolman
- Applicant: GlaxoSmithKline Biologicals S.A.
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- Agency: Seed IP Law Group LLP
- Priority: GB0421078.7 20040922; GB0421079.5 20040922; GB0421081.1 20040922; GB0421082.9 20040922; GB0503143.0 20050215
- Main IPC: A61K39/085
- IPC: A61K39/085 ; A61K39/116 ; A61K39/00 ; C07K16/12 ; A61K47/64

Abstract:
The present application relates to immunogenic compositions comprising a mixture of staphylococcal antigens which combines antigen having different functions, for instance, combinations including a staphylococcal extracellular component binding protein and a staphylococcal transporter protein or a staphylococcal extracellular component binding protein and a staphylococcal regulator of virulence or toxin or a staphylococcal transporter protein and a staphylococcal regulator of virulence or toxin. Vaccines, methods of treatment, uses of and processes to make a staphylococcal vaccine are also described.
Public/Granted literature
- US20190076516A1 IMMUNOGENIC COMPOSITION FOR USE IN VACCINATION AGAINST STAPHYLOCOCCI Public/Granted day:2019-03-14
Information query